PRP: More words than facts...

摘要

The use of platelet concentrates is not a new concept in medicine, but it is relatively new for clinical applications in orthopaedics aed sports medicine [9]. Interest in this biological approach has been aroused in these fields in recent years, after the comparative trial on the treatment of chronic elbow tendinosis published by Mishra et al. [6], which showed promising results, but even more so after anecdotal reports by the media at the beginning of 2009. This increasing interest is supported at different levels: in fact, the market on this blood derived product was evaluated 45 million dollar in 2009 and is expected to reach more than 120 million dollar in 2016 [3], and the literature also recorded an impressive number of new articles on this treatment.